News

The Merck Foundation hosted its 7th Merck Foundation First Ladies Initiative (MFFLI) Summit in Dubai, focusing on enhancing healthcare in Africa and Asia. Esteemed guests included First Ladies from 14 ...
In the latest trading session, Merck (MRK) closed at $79.29, marking a +1.29% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.03% for the day. On the other ...
Merck (NYSE:MRK) recently initiated the IDeate-Prostate01 phase 3 trial, dosing the first patient for its investigational drug ifinatamab deruxtecan, aimed at treating metastatic castration ...
Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.
The American Chemical Society Division of Public Relations (PROF) is seeking applications for the 2026 cycle of the ACS PRIDE Merck Graduate Research Award. The first recipients of the award were ...
Earlier, the Chairman of the Merck Foundation Board of Trustees, Prof. Dr. Frank Stangenberg-Haverkamp, applauded the First Ladies’ commitment to healthcare and social development.
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed its Neutral rating on Merck & Co., Inc.
Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment because ‘it has fundamentally changed me as a person’.
Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA).
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.